Sudarshan Jain

Reportedly, 400+ delegates and 50 speakers were part of the summit

Even as India’s biggest pharma companies pursue biosimilars, product recalls related to manufacturing defects threaten to queer…

The agency through a separate initiative also plans to make it easier for biosimilars to be developed as interchangeable with…

Programme offers funding support from idea to market across early and later stage projects, with enhanced incentives for strategic…

The session attracted over 250 attendees, reinforcing the PULSE series' role as a key learning platform for industry professionals

Trump’s new tariffs impose 26% duty on India, while pharma remains exempt. Industry experts weigh in on the impact

The Pharma Leadership and Innovation Conclave 2025 hosted a thought-provoking panel discussion on ‘The Patient of the Future:…

While the PILLS Act, aims for “strategically incentivising reshoring of essential medicines” to the US, India Pharma Inc cannot do…

Nutrify Today introduces instant commerce platform, reducing product development timelines for nutraceutical companies

Perhaps the uncertainty of the Union Budget pales before the changes that US President Trump will make as he gets down to business…